Brief: Orgenesis And Leidos Collaborate On Potential Treatment For Covid-19
22/06/2020 13:48
Orgenesis Inc ORGS.O :
* ORGENESIS AND LEIDOS COLLABORATE ON POTENTIAL TREATMENT
FOR
COVID-19
Source text for Eikon: ID:nGNX126d7V
Further company coverage: ORGS.O
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules